Reduced Rates of Severe Complications Following a Change in Anthracycline–Taxane Regimen for Early Breast Cancer: a Single Centre Experience.

MLA

Battisti, N., et al. “Reduced Rates of Severe Complications Following a Change in Anthracycline–Taxane Regimen for Early Breast Cancer: A Single Centre Experience.” Clinical Oncology, vol. 29, no. 6, June 2017, pp. e97–98. EBSCOhost, https://doi.org/10.1016/j.clon.2017.01.015.

APA

Battisti, N., Beaney, T., Redana, S., Iyer, R., Manickavasagar, T., & Ring, A. (2017). Reduced Rates of Severe Complications Following a Change in Anthracycline–Taxane Regimen for Early Breast Cancer: a Single Centre Experience. Clinical Oncology, 29(6), e97–e98. https://doi.org/10.1016/j.clon.2017.01.015

Chicago

Battisti, N., T. Beaney, S. Redana, R. Iyer, T. Manickavasagar, and A. Ring. 2017. “Reduced Rates of Severe Complications Following a Change in Anthracycline–Taxane Regimen for Early Breast Cancer: A Single Centre Experience.” Clinical Oncology 29 (6): e97–98. doi:10.1016/j.clon.2017.01.015.